Knowledge of the fibrinolytic system has for years been utilized in treatment of thromboembolic disorders like acute myocardial infarction, stroke or pulmonary embolism, by intravenous administration of recombinant tPA, or other plasminogen activators, dissolving the harming thrombus [5]. Here, PLAT is linked to myocardial infarction.